Brief: Talaris Therapeutics Announces Q1 Loss Per Share Of $1.30

Tourmaline Bio

14/06/2021 22:27

June 14 (Reuters) - Talaris Therapeutics Inc  TALS.O :
    * TALARIS THERAPEUTICS ANNOUNCES FIRST QUARTER 2021
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
    * Q1 LOSS PER SHARE $1.30
    * TALARIS THERAPEUTICS - FINISHED Q1 WITH $140.1 MILLION IN
CASH,
CASH EQUIVALENTS, MARKETABLE SECURITIES COMPARED WITH $149.5
MILLION AS OF DECEMBER 31, 2020

Source text for Eikon:  ID:nGNX8HK73m 
Further company coverage:  TALS.O 

 ((Reuters.Briefs@thomsonreuters.com;))